These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 7331126)

  • 1. Removal of low density lipoproteins in sheep by extracorporeal affinity chromatography.
    Schmer G; Rastelli L; Dennis MB; Hershon K; Young J; Chait A
    Trans Am Soc Artif Intern Organs; 1981; 27():547-9. PubMed ID: 7331126
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of double-filtration and affinity chromatographic techniques.
    Yamamoto A; Yokoyama S; Kojima S; Kawaguichi A; Bosch T
    Prog Clin Biol Res; 1990; 337():169-81. PubMed ID: 2352974
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin-induced extracorporeal low-density-lipoprotein plasmapheresis (HELP) and its use in heart transplant patients with severe hypercholesterolemia.
    Thiery J; Meiser B; Wenke K; Engelschalk C; Reichart B; Seidel D
    Transplant Proc; 1995 Jun; 27(3):1950-3. PubMed ID: 7792847
    [No Abstract]   [Full Text] [Related]  

  • 4. Methods for selective removal of plasma constituents.
    Pineda AA
    Prog Clin Biol Res; 1982; 106():361-73. PubMed ID: 6757950
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of bioaffinity technology in therapeutic extracorporeal plasmapheresis and large-scale fractionation of human plasma.
    Burnouf T; Goubran H; Radosevich M
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):65-80. PubMed ID: 9792498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
    Gordon BR; Saal SD
    J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of the matrix and its chemical activation on the stability of immuno-adsorbents.
    Ubrich N; Hubert P; Dellacherie E; Rivat C
    J Mol Recognit; 1995; 8(1-2):111-5. PubMed ID: 7598944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technological development of plasma epuration: treatment of the plasma].
    Schooneman F
    Ann Med Interne (Paris); 1994; 145(5):319-23. PubMed ID: 7985940
    [No Abstract]   [Full Text] [Related]  

  • 9. A newly developed LDL-binding material.
    Behm E; Loth F; Toewe D; Palm M; Zinner G; Ernst B; Böttcher M; Klinkmann H
    Prog Clin Biol Res; 1990; 337():195-9. PubMed ID: 2352976
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective removal of plasma components by high-performance immunoaffinity chromatography.
    Kojima K
    Ther Apher; 1997 May; 1(2):169-73. PubMed ID: 10225765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP).
    Lees RS; Holmes NN; Stadler RW; Ibrahim SF; Lees AM
    J Clin Apher; 1996; 11(3):132-7. PubMed ID: 8915817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid composition of polymodified (desialylated) low density lipoproteins].
    Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
    Biull Eksp Biol Med; 1996 Jul; 122(7):37-9. PubMed ID: 9303695
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity.
    Noto D; Rizzo M; Barbagallo CM; Cefalù AB; Verde AL; Fayer F; Notarbartolo A; Averna MR
    Metabolism; 2006 Oct; 55(10):1308-16. PubMed ID: 16979400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein plasmapheresis].
    Busnach G
    Cardiologia; 1998 Sep; 43(9):971-4. PubMed ID: 9859613
    [No Abstract]   [Full Text] [Related]  

  • 15. Accurate direct determination of low-density lipoprotein cholesterol using an immunoseparation reagent and enzymatic cholesterol assay.
    Pisani T; Gebski CP; Leary ET; Warnick GR; Ollington JF
    Arch Pathol Lab Med; 1995 Dec; 119(12):1127-35. PubMed ID: 7503661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.
    Amital H; Heilweil-Harel M; Ulmansky R; Harlev M; Toubi E; Hershko A; Naparstek Y
    Rheumatology (Oxford); 2007 Sep; 46(9):1433-7. PubMed ID: 17686790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexoproductive and antiheparin properties of low density lipoproteins (LDL). VI. Antiheparin activity in blood plasma of different species of vertebrates.
    Rółkowski R; Worowski K; Skrzydlewski Z
    Ann Med Univ Bialyst Pol; 1993; 38(1):56-9. PubMed ID: 7922486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein adsorption during LDL-apheresis: proteomic analysis.
    Dihazi H; Koziolek MJ; Söllner T; Kahler E; Klingel R; Neuhoff R; Strutz F; Mueller GA
    Nephrol Dial Transplant; 2008 Sep; 23(9):2925-35. PubMed ID: 18398017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma perfusion by apheresis through a gal immunoaffinity column successfully depletes anti-Gal antibody: experience with 275 aphereses in baboons.
    Watts A; Foley A; Awwad M; Treter S; Lambrigts D; Buhler L; Gojo S; Basker M; Oravec G; Sachs DH; Andrews D; Cooper DK
    Transplant Proc; 2000 Aug; 32(5):860. PubMed ID: 10936245
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer.
    Bailhache E; Briand F; Nguyen P; Krempf M; Magot T; Ouguerram K
    Eur J Clin Invest; 2004 Aug; 34(8):527-34. PubMed ID: 15305886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.